Recruiting studies: Common Variable Immunodeficiency

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Phase 2/Phase 3 · 3 location(s) · Monash University · NCT07202052 Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Phase 2 · 6 location(s) · Children's Hospital Medical Center, Cincinnati · NCT04925375 Immunoglobulin for Hypogammaglobulinemia Due to Chimeric Antigen Receptor T Cell Therapy
Phase N/A · 1 location(s) · University of Alberta · NCT06989541 Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease
Phase 4 · 1 location(s) · University of Alabama at Birmingham · NCT05193552 Exercise Intervention and Immunodeficiency
NA · 2 location(s) · Yale University · NCT07698197 Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifest
Phase 2 · 1 location(s) · Paul Szabolcs · NCT07284641 Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
Phase 2/Phase 3 · 7 location(s) · Monash University · NCT05678621 Natural History of Bronchiectasis
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00943514 Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04339777 Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00001244 Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Phase 2 · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT06976476 Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Phase 2 · 2 location(s) · National Cancer Institute (NCI) · NCT02579967

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.